Florida-based DBA Systems has received premarket approval from the Food and Drug Administration for its film mammogram review and analysis workstation, ImagClear Mammography Review System. The product line offers several different models. The main
Florida-based DBA Systems has received premarket approval from the Food and Drug Administration for its film mammogram review and analysis workstation, ImagClear Mammography Review System.
The product line offers several different models. The main modelsthe CV 6000, Tech 5000, and VS 500are ready and available for clinical use, said Glenn Turner, DBA Systems manager of medical research and development.
Company officials said they hope to bridge the gap between film-based and filmless technology with the ImagClear system.
The ImagClear uses hardware, software, and communications technology that allow a radiologist to apply digital imaging techniques to the viewing, manipulation, and communication of film mammograms. Image capture is accomplished through the ImagClear systems film digitizer, which provides a pixel resolution of 42 microns and a gray-scale range of 16 bits to produce a minimum 4K x 5K image matrix, which is adequate for even the highest quality mammography films.
The image viewing software ImagClear uses was specifically designed to meet the demanding requirements of mammography. Images from the ImagClear Film Digitizer can be organized into studies and sessions and the system creates online reports.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.